rs36021513

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_182914.3(SYNE2):​c.13254C>A​(p.Asn4418Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0169 in 1,613,784 control chromosomes in the GnomAD database, including 264 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 44 hom., cov: 32)
Exomes 𝑓: 0.016 ( 220 hom. )

Consequence

SYNE2
NM_182914.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0550
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
ESR2 (HGNC:3468): (estrogen receptor 2) This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023183823).
BP6
Variant 14-64122107-C-A is Benign according to our data. Variant chr14-64122107-C-A is described in ClinVar as [Benign]. Clinvar id is 130470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-64122107-C-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0224 (3404/152162) while in subpopulation AFR AF= 0.037 (1535/41504). AF 95% confidence interval is 0.0354. There are 44 homozygotes in gnomad4. There are 1693 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3404 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNE2NM_182914.3 linkuse as main transcriptc.13254C>A p.Asn4418Lys missense_variant 69/116 ENST00000555002.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNE2ENST00000555002.6 linkuse as main transcriptc.13254C>A p.Asn4418Lys missense_variant 69/1161 NM_182914.3 P4Q8WXH0-2

Frequencies

GnomAD3 genomes
AF:
0.0223
AC:
3398
AN:
152044
Hom.:
44
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0370
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.0187
Gnomad ASJ
AF:
0.0190
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0226
Gnomad FIN
AF:
0.0284
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0151
Gnomad OTH
AF:
0.0173
GnomAD3 exomes
AF:
0.0166
AC:
4159
AN:
251204
Hom.:
45
AF XY:
0.0169
AC XY:
2292
AN XY:
135776
show subpopulations
Gnomad AFR exome
AF:
0.0382
Gnomad AMR exome
AF:
0.00729
Gnomad ASJ exome
AF:
0.0180
Gnomad EAS exome
AF:
0.000435
Gnomad SAS exome
AF:
0.0222
Gnomad FIN exome
AF:
0.0251
Gnomad NFE exome
AF:
0.0155
Gnomad OTH exome
AF:
0.0191
GnomAD4 exome
AF:
0.0163
AC:
23868
AN:
1461622
Hom.:
220
Cov.:
32
AF XY:
0.0164
AC XY:
11945
AN XY:
727134
show subpopulations
Gnomad4 AFR exome
AF:
0.0375
Gnomad4 AMR exome
AF:
0.00767
Gnomad4 ASJ exome
AF:
0.0184
Gnomad4 EAS exome
AF:
0.000302
Gnomad4 SAS exome
AF:
0.0215
Gnomad4 FIN exome
AF:
0.0257
Gnomad4 NFE exome
AF:
0.0155
Gnomad4 OTH exome
AF:
0.0189
GnomAD4 genome
AF:
0.0224
AC:
3404
AN:
152162
Hom.:
44
Cov.:
32
AF XY:
0.0228
AC XY:
1693
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.0370
Gnomad4 AMR
AF:
0.0186
Gnomad4 ASJ
AF:
0.0190
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0226
Gnomad4 FIN
AF:
0.0284
Gnomad4 NFE
AF:
0.0151
Gnomad4 OTH
AF:
0.0190
Alfa
AF:
0.0152
Hom.:
22
Bravo
AF:
0.0218
TwinsUK
AF:
0.0151
AC:
56
ALSPAC
AF:
0.0145
AC:
56
ESP6500AA
AF:
0.0340
AC:
150
ESP6500EA
AF:
0.0155
AC:
133
ExAC
AF:
0.0169
AC:
2052
Asia WGS
AF:
0.0180
AC:
63
AN:
3478
EpiCase
AF:
0.0160
EpiControl
AF:
0.0136

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 19, 2019- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtOct 09, 2014- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
1.8
DANN
Benign
0.50
DEOGEN2
Benign
0.0025
.;T;T;T;T;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.00085
N
LIST_S2
Benign
0.033
T;T;T;T;T;T
MetaRNN
Benign
0.0023
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.3
N;.;N;.;.;.
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.36
N;.;N;N;N;N
REVEL
Benign
0.012
Sift
Benign
1.0
T;.;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;T
Polyphen
0.0
B;.;B;.;.;.
Vest4
0.060
MutPred
0.28
Gain of ubiquitination at N4418 (P = 0.0075);.;Gain of ubiquitination at N4418 (P = 0.0075);.;.;.;
MPC
0.052
ClinPred
0.00030
T
GERP RS
-0.77
Varity_R
0.024
gMVP
0.080

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs36021513; hg19: chr14-64588825; API